Am. J. Respir. Cell Mol. Biol., Vol 16, No. 4, Apr 1997, 398-406.
Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is downregulated by corticosteroids
M Nauck, M Roth, M Tamm, O Eickelberg, H Wieland, P Stulz and AP Perruchoud
Department of Medicine, University Hospital Freiburg, Germany.
Vascular endothelial growth factor (VEGF) is a potent peptide growth factor
specific for vascular endothelial cells, which promotes neovascularization
and increases vascular permeability in vivo. Enhanced microvascular
permeability and edema are common characteristics of inflammatory and
neoplastic disorders. Two proinflammatory mediators, platelet-activating
factor (PAF) and platelet-derived growth factor (PDGF), are known to
contribute to cellular damage and tissue remodeling in a number of lung
diseases. To determine whether PAF or PDGF induce VEGF gene expression in
primary cultures of human pulmonary fibroblasts and pulmonary vascular
smooth- muscle cells (VSMCs), we performed Northern-blot analysis and
enzyme- linked immunosorbent assays (EIA). PAF and all three isoforms of
PDGF (PDGF-AA, -AB, and -BB) increased VEGF mRNA in a time- and dose-
dependent manner. While PAF was shown to increase VEGF mRNA at picomolar
concentrations, all PDGF isoforms were effective in inducing VEGF mRNA at
nanomolar concentrations. The transcriptional activation was accompanied by
increased levels of VEGF protein as determined by EIA in culture medium.
These results indicate that VEGF gene expression in VSMCs and fibroblasts
is mediated by PAF and/or PDGF isoforms. In a paracrine mode of action,
secreted VEGF may then lead to altered endothelial cell functions and
vascular hyperpermeability. In the presence of the corticosteroids
cortisone, hydrocortisone, dexamethasone, or prednisolone at nanomolar
concentrations, this stimulus-dependent transcription of VEGF was
abolished. The inhibitory effect of corticosteroids on VEGF expression
could explain the clinically well-known antiedematous potency of
corticosteroids on a molecular level.
This article has been cited by other articles:

|
 |

|
 |
 
U H M Spandau, G Sauder, U Schubert, H-P Hammes, and J B Jonas
Effect of triamcinolone acetonide on proliferation of retinal endothelial cells in vitro and in vivo
Br. J. Ophthalmol.,
June 1, 2005;
89(6):
745 - 747.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Fong, L. P. Aiello, F. L. Ferris III, and R. Klein
Diabetic Retinopathy
Diabetes Care,
October 1, 2004;
27(10):
2540 - 2553.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Thomas, M. Keramidas, E. Monchaux, and J.-J. Feige
Dual Hormonal Regulation of Endocrine Tissue Mass and Vasculature by Adrenocorticotropin in the Adrenal Cortex
Endocrinology,
September 1, 2004;
145(9):
4320 - 4329.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Ip, J. L. Gottlieb, A. Kahana, I. U. Scott, M. M. Altaweel, B. A. Blodi, R. E. Gangnon, and C. A. Puliafito
Intravitreal Triamcinolone for the Treatment of Macular Edema Associated With Central Retinal Vein Occlusion
Arch Ophthalmol,
August 1, 2004;
122(8):
1131 - 1136.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Ip
Intravitreal Injection of Triamcinolone: An emerging treatment for diabetic macular edema
Diabetes Care,
July 1, 2004;
27(7):
1794 - 1797.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kanazawa, T. Yoshikawa, K. Hirata, and J. Yoshikawa
Effects of Pranlukast Administration on Vascular Endothelial Growth Factor Levels in Asthmatic Patients
Chest,
May 1, 2004;
125(5):
1700 - 1705.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Y. Cheung
Vascular Endothelial Growth Factor Activation of Intramembranous Absorption: A Critical Pathway for Amniotic Fluid Volume Regulation
Reproductive Sciences,
February 1, 2004;
11(2):
63 - 74.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Tanaka, G. Yamada, T. Saikai, M. Hashimoto, S. Tanaka, K. Suzuki, M. Fujii, H. Takahashi, and S. Abe
Increased Airway Vascularity in Newly Diagnosed Asthma Using a High-magnification Bronchovideoscope
Am. J. Respir. Crit. Care Med.,
December 15, 2003;
168(12):
1495 - 1499.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. E. Turner, A. L. Harris, S. Melmed, and J. A. H. Wass
Angiogenesis in Endocrine Tumors
Endocr. Rev.,
October 1, 2003;
24(5):
600 - 632.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. OSTERUD and E. BJORKLID
Role of Monocytes in Atherogenesis
Physiol Rev,
October 1, 2003;
83(4):
1069 - 1112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Vento, P. G. Matassa, E. Capoluongo, L. Tortorolo, C. Romagnoli, F. Ameglio, P. Lassus, and S. Andersson
Glucocorticoids in Preterm Infants and Discrepancies of Vascular Endothelial Growth Factor
Am. J. Respir. Crit. Care Med.,
August 15, 2003;
168(4):
501 - 502.
[Full Text]
|
 |
|

|
 |

|
 |
 
P. Guo, B. Hu, W. Gu, L. Xu, D. Wang, H.-J. S. Huang, W. K. Cavenee, and S.-Y. Cheng
Platelet-Derived Growth Factor-B Enhances Glioma Angiogenesis by Stimulating Vascular Endothelial Growth Factor Expression in Tumor Endothelia and by Promoting Pericyte Recruitment
Am. J. Pathol.,
April 1, 2003;
162(4):
1083 - 1093.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Mallet, O. Feraud, G. Ouengue-Mbele, I. Gaillard, N. Sappay, D. Vittet, and I. Vilgrain
Differential expression of VEGF receptors in adrenal atrophy induced by dexamethasone: a protective role of ACTH
Am J Physiol Endocrinol Metab,
January 1, 2003;
284(1):
E156 - E167.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H Kanazawa, K Hirata, and J Yoshikawa
Involvement of vascular endothelial growth factor in exercise induced bronchoconstriction in asthmatic patients
Thorax,
October 1, 2002;
57(10):
885 - 888.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Lassus, I. Nupponen, A. Kari, M. Pohjavuori, and S. Andersson
Early Postnatal Dexamethasone Decreases Hepatocyte Growth Factor in Tracheal Aspirate Fluid From Premature Infants
Pediatrics,
October 1, 2002;
110(4):
768 - 771.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. L. Derevjanik, S. A. Vinores, W.-H. Xiao, K. Mori, T. Turon, T. Hudish, S. Dong, and P. A. Campochiaro
Quantitative Assessment of the Integrity of the Blood-Retinal Barrier in Mice
Invest. Ophthalmol. Vis. Sci.,
July 1, 2002;
43(7):
2462 - 2467.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Metheny-Barlow, B. Flynn, H. E. van Gijssel, A. Marrogi, and B. I. Gerwin
Paradoxical Effects of Platelet-Derived Growth Factor-A Overexpression in Malignant Mesothelioma . Antiproliferative Effects In Vitro and Tumorigenic Stimulation In Vivo
Am. J. Respir. Cell Mol. Biol.,
June 1, 2001;
24(6):
694 - 702.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. C. Meyer, A. L. Cardoni, Z. Xiang, R. D. Cornwell, and R. B. Love
Vascular Endothelial Growth Factor in Human Lung Transplantation
Chest,
January 1, 2001;
119(1):
137 - 143.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Papakonstantinou, G. Karakiulakis, M. Tamm, A. P. Perruchoud, and M. Roth
Hypoxia modifies the effect of PDGF on glycosaminoglycan synthesis by primary human lung cells
Am J Physiol Lung Cell Mol Physiol,
November 1, 2000;
279(5):
L825 - L834.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Roth and L H Block
Distinct effects of Broncho-Vaxom (OM-85 BV) on gp130 binding cytokines
Thorax,
August 1, 2000;
55(8):
678 - 684.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. E. Olah and F. L. Roudabush
Down-Regulation of Vascular Endothelial Growth Factor Expression after A2A Adenosine Receptor Activation in PC12 Pheochromocytoma Cells
J. Pharmacol. Exp. Ther.,
June 1, 2000;
293(3):
779 - 787.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. BOUSQUET, P. K. JEFFERY, W. W. BUSSE, M. JOHNSON, and A. M. VIGNOLA
Asthma . From Bronchoconstriction to Airways Inflammation and Remodeling
Am. J. Respir. Crit. Care Med.,
May 1, 2000;
161(5):
1720 - 1745.
[Full Text]
|
 |
|

|
 |

|
 |
 
T. D. le Cras, N. E. Markham, K. G. Morris, C. R. Ahrens, I. F. McMurtry, and S. H. Abman
Neonatal dexamethasone treatment increases the risk for pulmonary hypertension in adult rats
Am J Physiol Lung Cell Mol Physiol,
April 1, 2000;
278(4):
L822 - L829.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.-s. Cheng, R. M. Rodriguez, E. A. Perkett, J. Rogers, G. Bienvenu, U. Lappalainen, and R. W. Light
Vascular Endothelial Growth Factor in Pleural Fluid
Chest,
September 1, 1999;
116(3):
760 - 765.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Cao, M. K. Mathews, D S. McLeod, C. Merges, L. M Hjelmeland, and G. A Lutty
Angiogenic factors in human proliferative sickle cell retinopathy
Br. J. Ophthalmol.,
July 1, 1999;
83(7):
838 - 846.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. LASSUS, A. RISTIMAKI, O. YLIKORKALA, L. VIINIKKA, and S. ANDERSSON
Vascular Endothelial Growth Factor in Human Preterm Lung
Am. J. Respir. Crit. Care Med.,
May 1, 1999;
159(5):
1429 - 1433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. E Orsida, X. Li, B. Hickey, F. Thien, J. W Wilson, and E H. Walters
Vascularity in asthmatic airways: relation to inhaled steroid dose
Thorax,
April 1, 1999;
54(4):
289 - 295.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
O. Eickelberg, M. Roth, R. Lorx, V. Bruce, J. Rudiger, M. Johnson, and L.-H. Block
Ligand-independent Activation of the Glucocorticoid Receptor by beta 2-Adrenergic Receptor Agonists in Primary Human Lung Fibroblasts and Vascular Smooth Muscle Cells
J. Biol. Chem.,
January 8, 1999;
274(2):
1005 - 1010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Acarregui, S. T. Penisten, K. L. Goss, K. Ramirez, and J. M. Snyder
Vascular Endothelial Growth Factor Gene Expression in Human Fetal Lung In Vitro
Am. J. Respir. Cell Mol. Biol.,
January 1, 1999;
20(1):
14 - 23.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. Montrucchio, A. Sapino, B. Bussolati, G. Ghisolfi, S. Rizea-Savu, L. Silvestro, E. Lupia, and G. Camussi
Potential Angiogenic Role of Platelet-Activating Factor in Human Breast Cancer
Am. J. Pathol.,
November 1, 1998;
153(5):
1589 - 1596.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tamm, M. Bihl, O. Eickelberg, P. Stulz, A. P. Perruchoud, and M. Roth
Hypoxia-Induced Interleukin-6 and Interleukin-8 Production Is Mediated by Platelet-Activating Factor and Platelet-Derived Growth Factor in Primary Human Lung Cells
Am. J. Respir. Cell Mol. Biol.,
October 1, 1998;
19(4):
653 - 661.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1997 American Thoracic Society.
|
|
|